Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

DexCom Inc. DXCM recently announced that its G7 Continuous Glucose Monitoring (CGM) System will be added to the Régie de l'assurance maladie du Québec (RAMQ) Public Prescription Drug Insurance Plan.

Additionally, regulatory progress with the 15-day G7 CGM could provide a long-term boost. While challenges such as competitive pressures and channel mix shifts remain, DexCom appears well ...

This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 product. Gross profit margins for 2025 are expected to improve by at ...

such as the more-oblong Dexcom G7, or the mushroom-shaped Guardian system from Medtronic. From the U.K. court's judgment, comparing Abbott's FreeStyle Libre CGM to Sinocare's iCan i3 on-body unit.

Its innovative CGM systems, like the G6 and the newer G7, offer real-time glucose level tracking, giving users actionable insights. The company has been concentrating on product development ...